Thursday , 21 November 2024

IJRPLS-2024: Volume-12, Issue-1

Review Article
Retrospective Study of Complications Risk factors and Management of Pancreatitis
B. Sivani*, SK. Meharunnisa
Ratnam Institute of Pharmacy, Pidthapolur (V), Muthukur (M), Nellore (Dt), Andhra Pradesh–524343, India.
DOI: https://doi.org/10.30904/j.ijrpls.2024.4686
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 1-4
Abstract | Full Article-PDF |

Research Article
Formulation and evaluation of enteric coated tablets of Pantoprazole
Marthala Vandana*, B. Ranganayakulu
Department of Pharmaceutics, Srinivasa Institute of Pharmaceutical Sciences, Peddasetty palle, Proddatur, A.P, India
DOI: https://doi.org/10.30904/j.ijrpls.2024.4656
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 5-12
Abstract | Full Article-PDF |
Research Article
Solubility Enhancement and Formulation of Lovastatin Self Emulsifying Drug Delivery System

Yernagu Sai Roopa 1, B. Venkata Ramana*2
1M. Pharm Student, Department of Pharmaceutics, Prabhath Institute of Pharmacy, Parnapally (Vil.), Bandiatmakur (MD), Nandyal Dist., Andhra Pradesh
2Associate Professor, Department of Pharmaceutics, Prabhath Institute of Pharmacy, Parnapally (Vil.), Bandiatmakur (MD), Nandyal Dist., Andhra Pradesh
DOI: https://doi.org/10.30904/j.ijrpls.2024.4685
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 13-19
Abstract | Full Article-PDF |
Research Article
Pharmacological and Toxicological Studies of Cyclosporine for Anti-Rheumatoid Activity

Sana Farheen1, *Priyanka.K2, Rangam Chariitha3
1,3Department of Pharmacology, Smt. Sarojini Ramulamma College of Pharmacy, Palamuru University, Mahabubnagar, Telangana

2Department of Pharmaceutical Analysis, Smt. Sarojini Ramulamma College of Pharmacy, Palamuru University, Mahabubnagar, Telangana
DOI: https://doi.org/10.30904/j.ijrpls.2024.4715
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 20-25
Abstract | Full Article-PDF |

Research Article
Design and Performance Evaluation of Unidirectional Buccal Patches Loaded with Carbamazepine: A Comprehensive Formulation Study

K. Jithendra Kumar*, M.V. Jhansipriya, Narapusetty Naidu
Department of Pharmaceutics, Bellamkonda Institute of Technology & Sciences, Kambhalapadu, Podili
DOI: https://doi.org/10.30904/j.ijrpls.2024.4721
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 26-30
Abstract | Full Article-PDF |
Research Article
To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients With Type 2 Diabetes Mellitus
Dr. S Kumar1, F. Musharraf2, M Jabbar3, T Hussen4, U Ubed5, N Jardaq6, T Alnuaymie7, A Karam8, B Saisayaq9, J Halabja10, BA Chawsh11, BP Shar12, D Rzgar13, AH Koprlu14, A Basheer15, B Ahmed16, S. Nouraldeen Ali17, B Haider18, W Karim19, S. Salahadeen20, Harishankar Sahu21, N Shelar22
1Pharmcology, Associate Vice President, Medical Affairs, Ajanta Pharma*
2Endocrinologist, Malikat Al Rahma Clinic, Erbil
3Endocrinologist, Diabetes Disease Center, Erbil
4Internist, Al Jumhury Hospital, Erbil
5Cardiologist, Cardiac Center, Erbil
6Internist, Mercy Polyclinic, Erbil
7Internist, Al Askari General Hospital, Mosul
8Internist, Shar Private Hospital, Sulaymaniyah
9Internist, Al Sadiq General hospital, Sulaymaniyah
10Internist, Halabja General Hospital, Branch of Diabetic & Metabolism
11Internist, College of Medicine, University of Sulaymaniyah
12 Internist, Shar Private Hospital, Sulaymaniyah
13Internist, Hawlati Polyclinic, Branch of Diabetic & Metabolism
14Internist, College of Medicine, Azady Hospital
15Internist, Qaiwan International University
16Internist, Al Qasa General Hospital
17Internist, Azadi Teaching Hospital, Branch of Diabetic & Metabolism
18Internist, Nawroz Private Hospital, Duhok
19Internist, College of Medicine, Garmian University
20Internist, Al Masa General Hospital Azady Hospital
21Group Product Manager, Ajanta Pharma Limited, Mumbai
22Sr Marketing Manager, Ajanta Pharma Limited, Mumbai
DOI: https://doi.org/10.30904/j.ijrpls.2024.4721
Int. J. Res. Pharm. Lif. Sci., 2024, 12(1): 31-37
Abstract | Full Article-PDF |

Scroll To Top